Table 1.

Baseline patient and treatment characteristics of irradiated patients.

	(n = 46)
Median Age (range) in years	61.0 (31.0 – 85.7)
Gender
Male	28 (60.9%)
Female	18 (39.1%)
T stage
T1-T1b	3 (6.5%)
T2 a	3 (6.5%)
T2b	40 (87.0%)
Grade
1–2	9 (19.6%)
3	37 (80.4%)
Histologic Subtypes
Undifferentiated Pleomorphic Sarcoma	33 (71.7%)
Liposarcoma	8 (17.4%)
Leiomyosarcoma	3 (6.5%)
Other	4 (8.7%)
Tumor Location
Upper Extremity	4 (8.8%)
Lower Extremity	35 (76.1%)
Abdomen/Pelvis	7 (15.2%)
Radiation Dose
50 Gy, 25fractions	42 (89.7%)
50.4 Gy, 28 fractions	4 (10.3%)
Median (Range), in Days, from Last Day of XRT to Surgery	28 (13–54)
Post-operative Chemotherapy
No	39 (84.8%)
Yes	7 (15.2%)